Literature DB >> 9108620

Human monoclonal recombinant Fabs specific for HCV antigens obtained by repertoire cloning in phage display combinatorial vectors.

P Plaisant1, R Burioni, A Manzin, L Solforosi, M Candela, A Gabrielli, G Fadda, M Clementi.   

Abstract

Molecular cloning of the antibody repertoire in phage display combinatorial vectors is a powerful method enabling the dissection of the immunoresponse against a given pathogen. In this paper we describe the construction of a combinatorial library displayed on phage surface, containing the antibody repertoire of a patient with high serological response against hepatitis C virus (HCV) antigens. Following selection of the library against solid-phase-bound antigen, sixteen human antibody Fab fragments able to bind to HCV-specific antigens were generated and studied for binding characteristics. The majority of them appeared to have specificity for the HCV c33 peptide. All the clones reacting with the c33 peptide shared the same heavy-chain CDR3 sequence. This is the first report of molecular cloning in a combinatorial phage display vector of the antibody repertoire of an anti-HCV-positive patient.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9108620     DOI: 10.1016/s0923-2516(97)89904-9

Source DB:  PubMed          Journal:  Res Virol        ISSN: 0923-2516


  12 in total

Review 1.  Development of anti-infectives using phage display: biological agents against bacteria, viruses, and parasites.

Authors:  Johnny X Huang; Sharon L Bishop-Hurley; Matthew A Cooper
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

2.  Mapping B-cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display libraries.

Authors:  F Bugli; N Mancini; C Y Kang; C Di Campli; A Grieco; A Manzin; A Gabrielli; A Gasbarrini; G Fadda; P E Varaldo; M Clementi; R Burioni
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

3.  Hepatitis C virus (HCV) infection may elicit neutralizing antibodies targeting epitopes conserved in all viral genotypes.

Authors:  Nicasio Mancini; Roberta A Diotti; Mario Perotti; Giuseppe Sautto; Nicola Clementi; Giovanni Nitti; Arvind H Patel; Jonathan K Ball; Massimo Clementi; Roberto Burioni
Journal:  PLoS One       Date:  2009-12-11       Impact factor: 3.240

4.  Intracytoplasmic stable expression of IgG1 antibody targeting NS3 helicase inhibits replication of highly efficient hepatitis C Virus 2a clone.

Authors:  Partha K Chandra; Sidhartha Hazari; Bret Poat; Feyza Gunduz; Ramesh Prabhu; Gerald Liu; Roberto Burioni; Massimo Clementi; Robert F Garry; Srikanta Dash
Journal:  Virol J       Date:  2010-06-07       Impact factor: 4.099

5.  Production and characterization of a human recombinant monoclonal Fab fragment specific for influenza A viruses.

Authors:  Alessandra Desogus; Roberto Burioni; Angela Ingianni; Francesca Bugli; Raffaello Pompei; Giovanni Fadda
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

6.  Inhibition of hepatitis C virus nonstructural protein, helicase activity, and viral replication by a recombinant human antibody clone.

Authors:  Ramesh Prabhu; Nutan Khalap; Roberto Burioni; Massimo Clementi; Robert F Garry; Srikanta Dash
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

7.  Isolation of human monoclonal antibodies from peripheral blood B cells.

Authors:  Jinghe Huang; Nicole A Doria-Rose; Nancy S Longo; Leo Laub; Chien-Li Lin; Ellen Turk; Byong H Kang; Stephen A Migueles; Robert T Bailer; John R Mascola; Mark Connors
Journal:  Nat Protoc       Date:  2013-09-12       Impact factor: 13.491

Review 8.  Discovery of Antivirals Using Phage Display.

Authors:  Esen Sokullu; Marie-Soleil Gauthier; Benoit Coulombe
Journal:  Viruses       Date:  2021-06-10       Impact factor: 5.048

Review 9.  Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens.

Authors:  Nicola Clementi; Nicasio Mancini; Laura Solforosi; Matteo Castelli; Massimo Clementi; Roberto Burioni
Journal:  Int J Mol Sci       Date:  2012-07-04       Impact factor: 6.208

Review 10.  Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines.

Authors:  Nicola Clementi; Elena Criscuolo; Matteo Castelli; Nicasio Mancini; Massimo Clementi; Roberto Burioni
Journal:  Viruses       Date:  2012-11-14       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.